Jul 2026· Topics in antiviral medicine· Vol 34 Ahead of Issue, pp.
1-10
· 0 citations
Medicine
TL;DR
The current guidelines for treating acute COVID-19 are outlined, information on the mechanistic rationale behind various published and ongoing clinical trials investigating potential long COVID therapeutic agents are summarized and information on the mechanistic rationale behind various published and ongoing clinical trials investigating potential long COVID therapeutic agents are summarized.
This narrative review provides a critical synthesis of current literature regarding the clinical presentations, potential mechanisms, and biomarkers associated with neurological involvement in Long COVID and helps define disease heterogeneity, support patient stratification, and guide future personalized therapeutic ap...
M. Bralic, F. Silconi, Vladimira Vuletić et al.· Journal of Clinical Medicine· 0 citations
Long COVID, also referred to in the literature as postacute sequelae of SARS-CoV-2 infection (PASC) or postacute COVID-19 syndrome (PACS), is a chronic and heterogeneous multisystem condition persisting beyond acute COVID-19. For consistency, this review uses the term “Long COVID” throughout; PASC and PACS are noted on...
Akhilesh Koli, Ayush Khangar, Sharmilla Khatri et al.· Infectious Diseases in Clini...· 0 citations
While most ARD patients demonstrated a detectable response, gender appeared to influence antibody levels, with females exhibiting a weaker response, which is consistent with the literature suggesting that vaccine efficacy may be reduced in immunocompromised populations.
Reza Farrokhseresht, Hanieh Roghanian, H. Samimagham et al.· Acta Medica Iranica· 0 citations
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has significantly affected global health, including maternal and perinatal outcomes. Although the acute phase of the pandemic has subsided, the continued emergence of new viral variants, waning population immuni...
M. Januszewski, L. Ziuzia-Januszewska, A. Jakimiuk· Ginekologia Polska· 0 citations
Since the onset of the COVID-19 pandemic in 2019, various vaccines have been developed to control its spread. Initially, conventional inactivated virus vaccines, such as CoronaVac (Sinovac), were introduced, followed by more advanced mRNA-based vaccines, such as BNT162b2 (Pfizer-BioNTech). COVID-19 vaccines have been a...
Aysegul Oz, B. O. Kurt, Onur Sivaz et al.· Sisli Etfal Hastanesi tip bu...· 0 citations
Post-acute sequelae of SARS-CoV-2 infection (PASC), or Long COVID, in the pediatric population present a complex clinical picture that has evolved from the initial pandemic waves to the current era characterized by omicron lineages and widespread vaccination. Understanding its prevalence, clinical trajectory, and evide...
Paquita R. Q. Donoso, Jaime V. M. Muñoz, Joba E. I. Imbaquingo et al.· International Journal of Con...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
